Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Pharma
Novo Nordisk to reduce supply of Victoza to make more Ozempic
To address shortages for its weight loss products, Novo Nordisk is reducing production of diabetes drug Victoza to make more Ozempic.
Kevin Dunleavy
Nov 22, 2023 10:55am
Export of Novo Nordisk's Ozempic could be banned in Germany
Nov 15, 2023 11:07am
UPDATED: Novo serves Lilly with obesity head-to-head trial
Nov 15, 2023 10:55am
Novo Nordisk touts Wegovy's value for heart disease patients
Nov 13, 2023 10:31am
Eli Lilly's new obesity drug name tests well
Nov 10, 2023 8:36am
With FDA nod, Lilly's weight loss drug Zepbound has arrived
Nov 8, 2023 1:53pm
